[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344961-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344961-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","4-hydroxybutyrate-4hb-released-from-poly-4-hydroxybutyrate-scaffolds-does-not-impact-hallmark-phenotypes-of-cancer-in-malignant-or-non-malignant-breast-cells","4-Hydroxybutyrate (4HB) released from poly-4-hydroxybutyrate scaffolds does not impact hallmark phenotypes of cancer in malignant or non-malignant breast cells","","Poly-4-hydroxybutyrate (P4HB) scaffolds are used to reinforce soft tissue in implant-based breast reconstruction after mastectomy. Because P4HB hydrolyzes to 4-hydroxybutyrate (4HB), assessing direct effects on cancer cells is crucial for oncologic safety. This study evaluates sodium 4-hydroxybutyrate (Na4HB) effects across multiple human breast cancer and epithelial cell types using in vitro assays aligned with hallmarks of cancer, testing whether 4HB alters malignant or non-malignant phenotypes at clinically relevant exposure levels.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/4-hydroxybutyrate-4hb-released-from-poly-4-hydroxybutyrate-scaffolds-does-not-impact-hallmark-phenotypes-of-cancer-in-malignant-or-non-malignant-breast-cells/344961/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/4-hydroxybutyrate-4hb-released-from-poly-4-hydroxybutyrate-scaffolds-does-not-impact-hallmark-phenotypes-of-cancer-in-malignant-or-non-malignant-breast-cells/344961.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about 4HB and cancer?","Question",{"text":63,"@type":64},"The study evaluates whether 4HB released from degrading P4HB scaffolds affects hallmark cancer phenotypes in malignant and non-malignant breast cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were clinically relevant 4HB exposure levels determined?",{"text":68,"@type":64},"The clinically relevant tissue concentration of 4HB was quantified using a rabbit model to measure 4HB in peri-implant tissue.",{"name":70,"@type":61,"acceptedAnswer":71},"Did Na4HB increase cancer-related phenotypes in breast cell models?",{"text":72,"@type":64},"No. Across multiple in vitro assays, Na4HB did not produce statistically significant increases in metabolic activity, proliferation, migration, or colony formation compared with controls.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344961,1790156197,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Elahi et al. Breast Cancer Research (2026) 28:60 Breast Cancer Research  \n[https://doi.org/10.1186/s13058-026-02234-7](https://doi.org/10.1186/s13058-026-02234-7)  \nRESEARCH Open Access  \n4-Hydroxybutyrate (4HB) released from poly-  4-hydroxybutyrate scaffolds does not impact hallmark phenotypes of cancer in malignant or non-malignant breast cells  \nSakib F. Elahi 1*, David P. Martin 1, Yong Wan2, Li Zhang3, Daniela J. Romero3, Remya Kommeri3, Madeline C. Cramer3, Linsey Reavie4, Adam C. Mercer 1, Diana Catalina Ardila1, George S. Hussey3 and Stephen F. Badylak3  \nAbstract  \nBackground Poly-4-hydroxybutyrate (P4HB) scaffolds are increasingly used to reinforce soft tissue during  \nimplant-based reconstruction after mastectomy. P4HB undergoes hydrolytic degradation to a natural metabolite, 4-hydroxybutyrate (4HB) . Understanding the direct effects of 4HB on cancer cells is essential for assessing the oncologic safety of P4HB scaffolds used in breast reconstruction surgery. The aim of this study was to evaluate the effects of sodium 4-hydroxybutyrate (Na4HB) on multiple, relevant human breast cancer and epithelial cell types using a panel of well-established in vitro assays aligned with several hallmarks of cancer.  \nMethods First, the clinically relevant tissue concentration of 4HB was determined via a rabbit model to quantify 4HB in the peri-implant tissue of P4HB scaffolds. Second, human breast cell types, including non-malignant HMECand MCF-10A, and cancerous MCF-7, BT-474 and MDA-MB-231, were exposed to Na4HB at up to 10X the clinically relevant tissue concentration. Cells were then evaluated for cancer related phenotypes: metabolic activity (MTT assay), proliferation (BrdU assay), migration (Scratch and Transwell assays), and colony formation (soft agar assays) . Specific inhibitory control compounds for each assay were included to confirm assay performance.  \nResults The average peri-implant concentration of 4HB was found to be 163 µM after a simulated 1-year implantation in a rabbit model. Across the five assays and all three Na4HB concentrations, ranging from below to over 10X the peri-implant level (70, 350, 1750 µM), there was no statistically significant increase in any cancer-related phenotype including metabolic activity, proliferation, migration and colony formation in either malignant or nonmalignant cell types compared to controls treated with either the PBS vehicle or sodium acetate as determined by one-way ANOVA followed by Tukey’s multiple comparison test (p >0. 05) .  \nConclusions This comprehensive, in vitro evaluation suggests that 4HB does not modify growth or activity of malignant or non-malignant breast cells at concentrations up to 10X the peri-implant level. While these findings suggest that 4HB released from degrading P4HB Scaffolds is unlikely to promote oncogenic behavior in vitro, further  \n*Correspondence: Sakib F. Elahi [Sakib.Elahi@bd.com](Sakib.Elahi@bd.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nElahi et a","cbCaihyhDFQCosLI","https://ap.wps.com/l/cbCaihyhDFQCosLI","pdf",3579253,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background","[{\"question\":\"What question does the study address about 4HB and cancer?\",\"answer\":\"The study evaluates whether 4HB released from degrading P4HB scaffolds affects hallmark cancer phenotypes in malignant and non-malignant breast cells.\"},{\"question\":\"How were clinically relevant 4HB exposure levels determined?\",\"answer\":\"The clinically relevant tissue concentration of 4HB was quantified using a rabbit model to measure 4HB in peri-implant tissue.\"},{\"question\":\"Did Na4HB increase cancer-related phenotypes in breast cell models?\",\"answer\":\"No. Across multiple in vitro assays, Na4HB did not produce statistically significant increases in metabolic activity, proliferation, migration, or colony formation compared with controls.\"}]","4-Hydroxybutyrate (4HB) released from poly-4-hydroxybutyrate scaffolds does not impact hallmark phenotypes of cancer in malignant or non-malignant breast cells | PDF",1790055969,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a060b0542d39b8299c37987f5cb3997.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fa05e8e516bb818af39c9183742301a.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f51d19b2c84000c175a4cfb168825625.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0a0743822d46b7c67caa91caed3668dc.webp",980,1306]